C

CytoTools AG
XETRA:T5O

Watchlist Manager
CytoTools AG
XETRA:T5O
Watchlist
Price: 101.26 EUR 0.98% Market Closed
Market Cap: 52.8m EUR
Have any thoughts about
CytoTools AG?
Write Note

CytoTools AG
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CytoTools AG
Net Income Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
C
CytoTools AG
XETRA:T5O
Net Income
-€1.7m
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
BioNTech SE
NASDAQ:BNTX
Net Income
€1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Net Income
-€456.3m
CAGR 3-Years
-49%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Net Income
-€97m
CAGR 3-Years
23%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Net Income
€127m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Formycon AG
XETRA:FYB
Net Income
€75.8m
CAGR 3-Years
N/A
CAGR 5-Years
61%
CAGR 10-Years
N/A

See Also

What is CytoTools AG's Net Income?
Net Income
-1.7m EUR

Based on the financial report for Jun 30, 2023, CytoTools AG's Net Income amounts to -1.7m EUR.

What is CytoTools AG's Net Income growth rate?
Net Income CAGR 10Y
-9%

Over the last year, the Net Income growth was 0%. The average annual Net Income growth rates for CytoTools AG have been -8% over the past three years , -10% over the past five years , and -9% over the past ten years .

Back to Top